| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 19 |
| 1 | LEVETIRACETAM IN SODIUM CHLORIDE | 19 |
| 2 | LEVETIRACETAM INJECTION | 19 |
| 3 | LEVETIRACETAM ORAL | 19 |
| 4 | LACOSAMIDE | 18 |
| 5 | CLOBAZAM | 17 |
| 6 | LAMOTIRIGINE | 9 |
| 7 | LAMOTRIGINE | 9 |
| 8 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 9 |
| 9 | LAMOTRIGINE EXTENDED-RELEASE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CERLIPONASE ALFA | 1 | 0.0019 |
| 1 | CLOBAZAM | 17 | 0.0010 |
| 2 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 3 | OXCARBAZEPINE | 9 | 0.0006 |
| 4 | BRIVARACETAM | 5 | 0.0005 |
| 5 | LACOSAMIDE | 18 | 0.0005 |
| 6 | ETHOSUXIMIDE | 1 | 0.0004 |
| 7 | MIDAZOLAM HYDROCHLORIDE | 8 | 0.0003 |
| 8 | ZONISAMIDE | 3 | 0.0003 |
| 9 | LEVETIRACETAM ORAL | 19 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 18 |
| 1 | Mood Stabilizer [EPC] | 12 |
| 2 | Anti-epileptic Agent [EPC] | 11 |
| 3 | Corticosteroid [EPC] | 8 |
| 4 | Atypical Antipsychotic [EPC] | 6 |
| 5 | General Anesthetic [EPC] | 5 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 7 | Human Immunoglobulin G [EPC] | 2 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| 9 | Alkylating Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | General Anesthetic [EPC] | 5 | 0.0001 |
| 1 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 2 | Mood Stabilizer [EPC] | 12 | 0.0001 |
| 3 | Anti-epileptic Agent [EPC] | 11 | 0.0000 |
| 4 | Benzodiazepine [EPC] | 18 | 0.0000 |
| 5 | Atypical Antipsychotic [EPC] | 6 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Corticosteroid [EPC] | 8 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 1 | 0.0000 |